The UK Department of Health and Social Care is tightening regulations on private ADHD and autism clinics following warnings of superficial assessments. A government-commissioned report suggests that inconsistent quality and aggressive marketing are driving an unsustainable surge in diagnoses.
The 252 per cent spending surge in private ADHD care
Spending on independent-sector ADHD provision has climbed by approximately 252 per cent over the last three years, according to the report led by UCL clinical psychologist Professor Peter Fonagy. This explosion in private sector growth occurred as the National Health Service (NHS) struggled to meet rising demand, creating a vacuum that independent firms were quick to fill.
The review warns that this rapid expansion has occurred without sufficient oversight. Currently, many of these independent clinics are not required to be regulated by the Care Quality Commission (CQC), nor are they mandated to share detailed statistics regarding their caseloads. This lack of transparency has led to concerns that financial incentives are prioritizing the volume of assessments over clinical accuracy .
How the Right to Choose policy drove costs to £1.5 million
The growth of these providers has been heavily fueled by the "Right to Choose" policy, which allows patients to select a qualified provider for diagnosis at the expense of the NHS. As reported in the source, this has led to extreme volatility in public spending; one integrated care board (ICB) saw its monthly expenditure jump from £146,000 in 2024-25 to £1.5 million last year.
The report suggests that existing payment structures may unintentionally encourage clinics to perform combined ADHD and autism assessments simply because they are more lucrative. This financial pressure, combined with the ability to advertise directly to the public on social media, has created a system where clinical need is often secondary to provider marketing.
Yvette Cooper's mandate for CQC regulation
Health Secretary Yvette Cooper has pledged to strengthen the oversight of neurodevelopmental services to prevent the over-diagnosis of children. The government intends to make all diagnostic assessments for ADHD and autism subject to CQC regulation, ensuring that consistent standards for training, data reporting, and quality are met across both public and private sectors.
Beyond regulation, the Department of Health and Social Care (DHSC) plans to ban the direct-to-public advertising of these assessment services. By removing the influence of social media marketing, the government aims to ensure that access to these critical diagnoses is based on clinical necessity rather than the reach of a clinic's advertising budget.
The 62 per cent GP acceptance rate and the 'shared care' gap
A critical failure in the current private model is the breakdown of "shared care arrangements," where NHS GPs take over the prescription of medication initiated by a private provider. The government-commissioned review found that only about 62 per cent of NHS GPs now accept these arrangements, leaving many families in a precarious position.
This gap means that patients who paid for private assessments may find themselves unable to access NHS prescriptions, forcing them to either pay for private medication indefinitely or rejoin the long NHS queue for a second diagnosis.. this creates a scenario where a private diagnosis is not the start of treatment, but rather the beginning of another waiting period.
Several questions remain regarding the implementation of these changes. It is unclear how the government will enforce advertising bans on global social media platforms or how the CQC will manage the sudden influx of thousands of previously unregulated clinics. Furthermore, the report does not specify how patients currenly caught in the "shared care" gap will be transitioned back into the public system without further delays.
Comments 0